BOCA RATON, FL – 21/03/2026 – (SeaPRwire) – Carmed Pharmaceuticals, a research-oriented company focused on standardized botanical formulations, has initiated its expansion into the United States, marking a new phase in its international growth strategy. The move reflects the company’s continued emphasis on integrating scientifically validated approaches into the development of plant-based wellness solutions.
Founded in 2019 by Mustafa Can, Carmed Pharmaceuticals emerged from years of independent scientific inquiry into botanical bioactives, particularly carvacrol and its role in mechanism-based formulation design. The company has since evolved into a structured organization dedicated to bridging traditional botanical knowledge with modern pharmaceutical methodologies.
Carmed’s development philosophy centers on creating formulations that are standardized, reproducible, and supported by analytical validation. Its product design framework focuses on supporting immune resilience, cellular function, and overall physiological balance through carefully engineered combinations of bioactive compounds.
Founder’s Background and Scientific Direction
Mustafa Can, the founder of Carmed Pharmaceuticals, transitioned into the field of botanical research following a career in the maritime industry, where he served as a ship master. His shift toward preventive wellness and longevity research led to an intensive period of self-directed scientific study, including the review of extensive academic literature and exploration of phytochemical interactions.
Over time, this independent research developed into a focused effort to understand and standardize bioactive botanical compounds. Today, Carmed operates with a dedicated team of approximately 25 professionals and collaborates with a broader network of physicians, laboratories, and research institutions to support formulation development and scientific evaluation.
According to company statements, Carmed’s long-term strategy prioritizes reinvestment in research and development, with a strong focus on advancing formulation science and maintaining rigorous quality standards.
“Our approach is grounded in scientific discipline, with an emphasis on standardization and reproducibility,” Can noted. “Each formulation is designed based on a clear and measurable scientific rationale.”
Research Framework and Manufacturing Standards
Carmed Pharmaceuticals employs a research-driven model that includes in vitro studies, mechanism-based evaluations, and structured quality control systems. All products are manufactured in facilities operating under Good Manufacturing Practice (GMP) standards and in alignment with applicable regulatory requirements.
Product Portfolio for the U.S. Market
As part of its U.S. market entry, the company plans to introduce several key formulations:
- Vacrol® Kids Spray – A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children aged 4–11.
- S-Mix® – A multi-component formulation designed to support immune function and healthy cellular activity.
- Vacrol® Capsule – A standardized carvacrol-based supplement aimed at supporting microbial balance and immune resilience.
- Vacrol-M® Capsule – A botanical blend formulated to support respiratory wellness and immune system function.
- Omevaq-3® – A targeted formulation developed to support cellular energy metabolism and cognitive health.
Select products, including Vacrol® Kids Spray and S-Mix®, are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.
The company describes its formulation approach as “rational synergy,” referring to the strategic combination of multiple bioactive ingredients designed to interact across different biological pathways in a consistent and reproducible manner.
Scientific Collaboration and Future Outlook
Carmed’s research initiatives are supported through collaborations with academic institutions and scientific laboratories. In January 2026, a peer-reviewed study published in the journal Plants examined the company’s Vacrol® and S-Mix® formulations in preclinical laboratory and in ovo models, contributing to ongoing research into carvacrol-based compounds and multi-ingredient botanical systems.
The company emphasizes that such studies are part of broader scientific exploration and are not intended to support claims related to the diagnosis, treatment, cure, or prevention of diseases.
As Carmed Pharmaceuticals enters the U.S. market, its strategic focus includes regulatory compliance, scientific credibility, and long-term positioning within the preventive wellness sector. Additional details regarding distribution and retail availability are expected to be announced in the coming months.
About Carmed Pharmaceuticals
Carmed Pharmaceuticals is a science-driven company specializing in standardized botanical formulations based on mechanism-oriented design principles. Drawing on Anatolia’s botanical heritage, the company integrates traditional plant knowledge with modern pharmaceutical technologies to develop reproducible and quality-controlled products.
Established in 2019 following years of prior research, Carmed operates with nearly 15 years of cumulative industry experience. Its manufacturing processes adhere to Good Manufacturing Practice (GMP) standards, with a focus on safety, environmental responsibility, and continuous quality improvement.
The company develops formulations aimed at supporting preventive wellness, immune resilience, and cellular health through scientifically informed methodologies.
source https://newsroom.seaprwire.com/technologies/carmed-pharmaceuticals-advances-u-s-entry-with-science-driven-botanical-formulations/